StockData
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc. (NUS) stock

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)

Close on Nov 17, 2026Market cap $184.00MP/E –Yield –

Nu Skin Enterprises operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nu Skin Enterprises's operating cash flow for the twelve months ending Sep 30, 2026 was $15.21M, down 83.0% year over year. For fiscal 2025 it was $80.29M, down 28.2% from the year before. Over ten years it grew -13.0% a year on average. The highest annual figure on record is $530.18M in fiscal 2013.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.29M-28.2%
FY2024Dec 31, 2024$111.74M-5.8%
FY2023Dec 31, 2023$118.64M+9.8%
FY2022Dec 31, 2022$108.06M-23.7%
FY2021Dec 31, 2021$141.58M-62.7%
FY2020Dec 31, 2020$379.14M+113.1%
FY2019Dec 31, 2019$177.93M-12.2%
FY2018Dec 31, 2018$202.74M-33.0%
FY2017Dec 31, 2017$302.56M+9.9%
FY2016Dec 31, 2016$275.26M-14.5%
FY2015Dec 31, 2015$322.11M–
FY2014Dec 31, 2014-$56.46M-110.7%
FY2013Dec 31, 2013$530.18M+70.5%
FY2012Dec 31, 2012$310.98M+38.6%
FY2011Dec 31, 2011$224.32M+19.4%
FY2010Dec 31, 2010$187.88M+40.3%
FY2009Dec 31, 2009$133.94M+29.7%
FY2008Dec 31, 2008$103.31M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$8.12M-129.6%
Q2 FY2026Jun 30, 2026$10.63M-70.3%
Q1 FY2026Mar 31, 2026-$3.92M-1107.5%
Q4 FY2025Dec 31, 2025$16.62M-35.5%
Q3 FY2025Sep 30, 2025$27.48M-12.6%
Q2 FY2025Jun 30, 2025$35.80M-30.1%
Q1 FY2025Mar 31, 2025$389.00K-88.3%
Q4 FY2024Dec 31, 2024$25.79M-52.4%
Q3 FY2024Sep 30, 2024$31.43M-38.4%
Q2 FY2024Jun 30, 2024$51.21M+44.2%
Q1 FY2024Mar 31, 2024$3.32M–
Q4 FY2023Dec 31, 2023$54.17M+112.2%
Q3 FY2023Sep 30, 2023$51.03M+79.4%
Q2 FY2023Jun 30, 2023$35.52M-23.7%
Q1 FY2023Mar 31, 2023-$22.08M-392.8%
Q4 FY2022Dec 31, 2022$25.53M-76.7%
Q3 FY2022Sep 30, 2022$28.44M-5.9%
Q2 FY2022Jun 30, 2022$46.56M+124.7%
Q1 FY2022Mar 31, 2022$7.54M–
Q4 FY2021Dec 31, 2021$109.51M+15.6%
Q3 FY2021Sep 30, 2021$30.21M-74.5%
Q2 FY2021Jun 30, 2021$20.72M-78.7%
Q1 FY2021Mar 31, 2021-$18.86M-127.3%
Q4 FY2020Dec 31, 2020$94.69M+89.8%
Q3 FY2020Sep 30, 2020$118.37M+121.0%
Q2 FY2020Jun 30, 2020$97.05M+17.4%
Q1 FY2020Mar 31, 2020$69.03M–
Q4 FY2019Dec 31, 2019$49.90M-43.9%
Q3 FY2019Sep 30, 2019$53.55M-13.5%
Q2 FY2019Jun 30, 2019$82.66M+55.8%
Q1 FY2019Mar 31, 2019-$8.19M–
Q4 FY2018Dec 31, 2018$88.89M-39.4%
Q3 FY2018Sep 30, 2018$61.92M-13.7%
Q2 FY2018Jun 30, 2018$53.05M-15.4%
Q1 FY2018Mar 31, 2018-$1.11M-105.2%
Q4 FY2017Dec 31, 2017$146.75M+63.4%
Q3 FY2017Sep 30, 2017$71.78M–
Q2 FY2017Jun 30, 2017$62.70M–
Q1 FY2017Mar 31, 2017$21.33M–
Q4 FY2016Dec 31, 2016$89.83M–

More Nu Skin Enterprises figures

See a number that looks wrong?